Literature DB >> 6286501

Pivmecillinam in complicated urinary infections failing to respond to conventional therapy.

W Brumfitt, J M Hamilton-Miller.   

Abstract

Forty-three patients with a history of recurrent urinary infections, many of whom had renal involvement and had recently failed treatment, were then treated with pivmecillinam (400 mg 8-hourly for seven days). One week after the end of treatment the bacteriological cure rate was 72.1%. During the following four weeks, however, several of the cured patients relapsed, so that the cure rate five weeks after the end of treatment was only 46%. Thus, it is recommended that such patients should begin prophylactic treatment if found to be abacteriuric after the one week follow-up. Pivmecillinam was extremely well tolerated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286501     DOI: 10.1007/bf01640765

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  Pharmacokinetic and therapeutic studies of pivmecillinam in patients with normal and impaired renal function.

Authors:  M Ekberg; T Denneberg; S Larsson; I Juhlin
Journal:  Scand J Infect Dis       Date:  1978

2.  The use of a single 1 g dose of amoxycillin for the treatment of acute urinary tract infections.

Authors:  J D Anderson; M Y Aird; A M Johnson; R Ree; D Goresky; C A Brumwell; R K Percival-Smith
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

3.  6 -amidinopenicillanic acids--a new group of antibiotics.

Authors:  F Lund; L Tybring
Journal:  Nat New Biol       Date:  1972-04-05

4.  Treatment of recurrent bacteriuria with pivmecillinam (FL 1039).

Authors:  E R Verrier Jones; A W Asscher
Journal:  J Antimicrob Chemother       Date:  1975-06       Impact factor: 5.790

5.  Duration of pivmecillinam treatment of urinary tract infections in hospital in-patients.

Authors:  D C Shanson; M E Edmonds; J Midgley
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

6.  Comparative efficacy of 3-day and 7-day chemotherapy with pivmecillinam in urinary tract infections in general practice.

Authors:  B T Marsh; A P Menday
Journal:  J Int Med Res       Date:  1980       Impact factor: 1.671

7.  A comparative trial of co-trimoxazole and cephradine in patients with recurrent urinary infections.

Authors:  J Copper; W Brumfitt; J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

8.  Comparison of pivmecillinam and cephradine in bacteriuria in pregnancy and in acute urinary tract infection.

Authors:  W Brumfitt; I Franklin; J Hamilton-Miller; F Anderson
Journal:  Scand J Infect Dis       Date:  1979

9.  Three-day and ten-day chemotherapy for urinary tract infections in general practice.

Authors:  C A Charlton; A Crowther; J G Davies; J Dynes; M W Haward; P G Mann; S Rye
Journal:  Br Med J       Date:  1976-01-17

10.  Biotyping of Escherichia coli.

Authors:  P B Crichton; D C Old
Journal:  J Med Microbiol       Date:  1979-11       Impact factor: 2.472

View more
  2 in total

1.  Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

2.  Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections.

Authors:  W Brumfitt; J M Hamilton-Miller; H Ludlam; V Damjanovic; R Gargan
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.